Pfizer stock is rallying after its CEO Albert Bourla defended plans to sell its Covid-19 vaccine at a profit. Critics argue that pharma companies shouldn’t profit from coronavirus vaccines, mainly when they receive government money. This likely won’t stop Pfizer, which expects Covid-19 to be a seasonal illness like the flu. Pfizer (NYSE:PFE) stock jumped…